-
Study aim
-
Using the results of this study to reduce the dose of propofol and use dexmedtomidine and reduce respiratory complications in patients and reduce recovery time
-
Design
-
The clinical trial with control group, with parallel, double-blind, randomized, phase 3 groups on 70 patients, patients with simple randomization of quadruple permutation block will be divided into the first and second groups that the first group receive propofol, intravenous ketamine and the second group will receive propofol and dexmedtomidine.
-
Settings and conduct
-
. Outpatient colonoscopy patients referred to Imam Khomeini Hospital in Ahvaz will be divided into two groups ،The present study is two-blind so that patients and physicians will be unaware of the allocation of both groups.
-
Participants/Inclusion and exclusion criteria
-
No cardiovascular disease, renal or liver failure, no drug addiction, no dexmedomidine contraindications, propofol, which are classified in class 1 and 2 of the American Society of Anesthesiology), and II,I class ASA) are selected.
-
Intervention groups
-
The first group will be given propofol with a dose of 0.5mg per kg and dexmethomidine at a dose of 1 mg per kg at a rate of 0.5 mg per kg per hour, and the second group will be given propofol at a dose of 0.5 mg per kg and ketamine at a dose of 0.5 mg per kg.
-
Main outcome variables
-
Sedation rate, hemodynamic instability, drug level